UK markets close in 30 minutes

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
89.63+9.15 (+11.37%)
As of 11:39AM GMT. Market open.
Currency in EUR

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3N/A
S&P500 52-week change 333.64%
52-week high 3104.39
52-week low 3104.39
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.5B
Implied shares outstanding 6N/A
Float 81.74B
% held by insiders 10.12%
% held by institutions 168.85%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 35.08
Trailing annual dividend yield 36.31%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 12.40%
Operating margin (ttm)35.17%

Management effectiveness

Return on assets (ttm)7.94%
Return on equity (ttm)48.86%

Income statement

Revenue (ttm)53.73B
Revenue per share (ttm)30.36
Quarterly revenue growth (yoy)33.90%
Gross profit (ttm)31.75B
EBITDA 27.67B
Net income avi to common (ttm)6.6B
Diluted EPS (ttm)3.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.6B
Total cash per share (mrq)4.87
Total debt (mrq)82.16B
Total debt/equity (mrq)652.34
Current ratio (mrq)0.91
Book value per share (mrq)7.11

Cash flow statement

Operating cash flow (ttm)20.45B
Levered free cash flow (ttm)18.18B